Volume 9,Issue 2,2023 Table of Contents

   
Other Issues:  
  

综述

Research progress on immunotherapy for cholangiocarcinoma targeting the tumor immune microenvironment
  Tianyin Ma,Zhang Chen,Yibo Chai,Xiangdong Gongye,Peng Xia,Chenming Qu,Ming Tian and Yufeng Yuan
  2023,9(2):49-55 [Abstract(1961)]  [View PDF 261.79 K (1995)]
  
Role of miRNA-21 in radiation-induced heart disease
  Zhijie Fan,Motuma Yigezu Daba,Xiaoling Yan and Xianglin Yuan
  2023,9(2):56-65 [Abstract(1660)]  [View PDF 939.02 K (1878)]
  

病例报道

Successful surgical resection of large hepatocellular carcinoma with portal vein tumor thrombus after conversion therapy with mFOLFOX-HAIC combined with donafenib and sintilimab: two case reports and a literature review
  Zhitang Guo,Ming Zhang,Ang Liu,Zhihong Zhang,Kejia Li and Jiayun Ge
  2023,9(2):66-72 [Abstract(1775)]  [View PDF 875.24 K (1913)]
  

论著

The correlation between the hemoglobin-to-red cell distribution width ratio and all-cause mortality in patients with malignant tumors and sepsis: A retrospective cohort study using the MIMIC-IV database
  Shu Zhang,Shan Xu,Rui Liao and Kaixiu Qin
  2023,9(2):73-81 [Abstract(1599)]  [View PDF 651.65 K (1900)]
  
Development of a redox-related prognostic signature for predicting biochemical-recurrence-free survival of prostate cancer
  Peng Hu,Guoda Song,Bingliang Chen and Jianping Miao
  2023,9(2):82-92 [Abstract(1587)]  [View PDF 2.41 M (1950)]
  
Preliminary security investigation and shorttime follow-up of intraoperative intraperitoneal chemotherapy with lobaplatin for advanced colorectal cancer
  Qin Li,Xianrong Li,Libo Feng,Xiaolong Chen,Dong Xia and Linxia Xu
  2023,9(2):93-98 [Abstract(1602)]  [View PDF 239.43 K (1827)]